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Abstract
Introduction and hypothesis There is evidence that in nonsur-
gical populations, pelvic floor muscle training (PFMT) and
lifestyle advice improves symptoms and stage of pelvic organ
prolapse (POP). Some women, however, require surgery, after
which de novo symptoms can develop or additional surgery is
required due to recurrence. Robust evidence is required as to
the benefit of perioperative PFMT in the postsurgery reduction
of symptoms and POP recurrence. The aim of this study was
to assess the feasibility of and collect pilot data to inform
sample size (SS) calculation for a multicentre randomised
controlled trial (RCT) of perioperative PFMT following sur-
gical intervention for POP.
Methods Fifty-seven participants were recruited and
randomised to a treatment group (one pre and six postopera-
tive PFMT sessions) or a control group (usual care). The
primary outcome measure was the Pelvic Organ Prolapse
Symptom Score (POP-SS) at 12 months; secondary outcome
measures included measurement of prolapse, the pelvic floor
and questionnaires relating to urinary and bowel incontinence.
All outcomes were measured at 0, 6 and 12 months.
Results Information on recruitment, retention and appropri-
ateness of outcome measures for a definitive trial was gath-
ered, and data enabled us to undertake an SS calculation.
When compared with the control group (n=29), benefits to
the intervention group (n=28) were observed in terms of fewer
prolapse symptoms at 12 months [mean difference 3.94; 95 %
confidence interval (CI) 1.35–6.75; t=3.24, p=0.006]; how-
ever, these results must be viewed with caution due to possible
selection bias.
Conclusion With modifications to design identified in this
pilot study, a multicentre RCT is feasible.
Keywords Prolapses . Pelvic floor muscle training .
Recurrence . Symptoms . Trial
Introduction
Pelvic organ prolapse (POP) is a common condition
characterised by symptomatic descent of the vaginal walls
and/or uterus or vaginal vault from their normal anatomical
position [1]. Estimates of prevalence of POP in the general
population are variable; however, in a sample of 2,979 women
between 45 and 86 years of age, reported in 2010, 21 % were
found to be symptomatic [2]. Women with prolapse may
present with vaginal, bladder, bowel, musculoskeletal and
sexual symptoms. Those women with symptomatic POP
who fail or decline conservative management are candidates
for surgery, with 80–90 % being undertaken by the vaginal
route [3]. Surgery will attempt to restore normal vaginal
compartments and re-establish or maintain normal urinary,
rectal and sexual functions whilst attempting to minimise
adverse effects [4]. Women have an 11 % risk of undergoing
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at least one surgical intervention for POP or incontinence by
the age of 79 years, and due to our increasing ageing popula-
tion, it has been suggested that this risk might double in the
next 30 years [5, 6]. The long-term outcome following surgi-
cal correction of POP is poor, and in a prospective study, 41%
of women had recurrence of POP at 5 years, and 10 % of
women had undergone a repeat POP operation within 5 years
of their index operation [7].
The pelvic floor muscles (PFMs) are an integral component
of the support mechanism of the pelvic organs. Bø reviewed
basic research and case–control studies and put forward two
hypotheses [8]:
1. Women can build upmuscle tone and structural support of
the PFMs through regular strength training over time.
2. Women can learn to contract their PFMs consciously
before and during an increase in intra-abdominal pressure
and will continue to make such contractions as a behav-
ioural modification in order to prevent descent of the
pelvic contents.
In addition, a study by Braekken et al. [9] demonstrated
elevation of the pelvic organs and reduction in the levator hiatal
area after PFMTand assumed that PFMTcan be used to prevent
POP. We therefore hypothesised that women who have been
taught and encouraged to perform PFM exercises, will have
established a coordinated muscular support mechanism to with-
stand increases in intra-abdominal pressure and for that reason
they will experience fewer POP symptoms after surgery and
have a reduced rate of POP recurrence in the long term.
In 2008, a UK survey of members of the Association of
Chartered Physiotherapists in Women’s Health (ACPWH)
was undertaken [10]. It was evident that there is wide variation
in practice amongst physiotherapists in terms of the interven-
tion they provide for women undergoing prolapse surgery.
Respondents reported that there was a lack of evidence for
their intervention and many felt dissatisfied with this situation.
International surveys of physiotherapy practice following sur-
gery for POP have reported similar findings [10–13].
Some studies in nonsurgical populations support PFMT as
a treatment in its own right in women with POP [9, 14].
However, a review of the literature relating to perioperative
physiotherapy in benign gynaecological conditions only iden-
tified two small randomised controlled trials (RCT) [15, 16]
on the subject, neither of which reported on POP symptoms.
Jarvis et al. reported on a two-group RCT (n=30 per group)
with results suggesting a significant benefit in women who
received treatment; however, conclusions were limited due to
the short length of follow-up and a lack of prolapse-specific
outcome measures [15]. Frawley et al. reported a two-group
RCT (n=25 per group) that showed no significant differences
between groups [16]. The paper presented here reports on a
study, including a pilot trial, to evaluate the feasibility of a
multicentre RCT to assess the effectiveness of perioperative
PFMT and lifestyle advice for women who are undergoing
surgery for POP and is the first to use a POP-specific ques-
tionnaire as an outcome measure; this was designated as the
SUrgery and Physiotherapy for prolapsE Research feasibility
study (SUPER) study, the aims of which were:
1. To develop the methods and assess the feasibility of a
multicentre RCT of perioperative PFMT and lifestyle
advice for women undergoing surgical intervention for
POP. Information on recruitment, retention and suitability
of outcome measures specific to POP and associated
symptoms were sought.
2. To collect pilot trial data to inform sample-size calcula-
tions and optimal health economic methods in preparation
for undertaking a multicentre pragmatic RCT.
Methods
Ethical approval was granted at the three centres (West of
Scotland Rec 5, 15 September 2010, 101001/45; Newcastle
Ref 5494, 23 November 2010; Southampton RHM O &
G0177, 19 January 2011; Belfast Ref 10192DMcC-SC, 10
June 2011). Our target sample size was 30 per group. This
number was based on (1) the prediction (based on patient
numbers) that each of the three centres could recruit 20 par-
ticipants (ten in each group) in the time provided; (2) our
experience of recruitment in similar pilot studies; and (3) that
this number would be sufficient to test out recruitment,
randomisation, intervention, follow-up processes and provide
data for a sample size calculation [17]. Women who attended
the gynaecological clinic and for whom primary surgery was
recommended due to their POP symptoms were asked to
participate in the trial. If they were interested and completed
the consent form, the patient was randomised using a remote
computer programme that then sent an email with the group
allocation of the participant to the researcher, using the iden-
tification code initially assigned to the participant.
Minimisation variable was included for each centre.
Randomisation was to the treatment (TG) or the control
(CG) group. TG patients (n=28), received perioperative
PFMT by a women’s health physiotherapist [treatment phy-
siotherapist (TP)]. This standardised intervention included:
& A preoperative appointment
A standardised history was taken. Anatomy and func-
tion of PFMs was discussed and types of prolapse de-
scribed using diagrams and a model of the pelvis. The
proposed surgical procedure was discussed and informa-
tion provided about recovery and return to normal activi-
ties of daily living (ADL). Women were taught (by digital
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palpation) how to correctly contract their PFMs and how to
precontract against increases in intra-abdominal pressure
(the knack) [18]. At this visit, women were advised to do
three sets of ten maximum contractions (up to 10-s hold)
per day with 4-s rest between sets, following by a 1-min
rest followed by ten fast contractions.
& Postdischarge
During the postdischarge week, the TG were mailed a
lifestyle advice leaflet specifically devised for use in the
SUPER study. This contained information on types of
prolapse; advice on recovery during the early postopera-
tive phase; and advice on avoidance of constipation, heavy
lifting, high-impact exercise and correct technique of
defaecation and bracing before coughing and lifting. The
women in this group were also telephoned once during
this week by a member of the research team to answer
questions relating to their recovery.
& Outpatient appointments
During the first outpatient session (at week 6), a brief
history of postoperative recovery was recorded, and a
repeat vaginal examination assessed the participant’s abil-
ity to contract their PFMs. Five further weekly physiother-
apy outpatient appointments within a period of 12 weeks
were provided. An individualised home exercise pro-
gramme was prescribed, with progression dictated by
improvement in PFM function. To facilitate PFM contrac-
tion and encourage adherence, physiotherapists were
allowed to use adjuncts such as biofeedback, electrical
stimulation and exercise balls, as per their usual practice.
Symptom changes, compliance with lifestyle advice and
changes in PFM strength were recorded at each subse-
quent consultation, and the content of the home exercise
programme was adjusted accordingly.
Control group (CG) patients (n=29), were mailed the same
lifestyle advice leaflet as those in the TG. This group did not
see a research physiotherapist and had no planned contact
with the hospital until the follow-up gynaecology appoint-
ments relating to their surgery.
In order to standardise the physiotherapy intervention, all
study sites were visited by the study chief investigator, who
gave instruction in the delivery of the lifestyle advice, content
of the appointments, use of diaries and standardised leaflet and
clinical documents. All study physiotherapists were experi-
enced in the delivery of PFMT. In all other respects, study
groups received postoperative advice as per local practice; e.g.
a locally approved advice leaflet and/or a brief discussion with
a women’s health physiotherapist or nurse.
Outcome measurement
Both groups of women completed postal questionnaires at
three times points: baseline (immediately prior to
randomisation), and at 6 and 12 months after randomisation.
The outcome of primary interest was prolapse symptom se-
verity as measured by the Pelvic Organ Prolapse Symptom
Score (POP-SS). This is a validated, self-completed, seven-
item questionnaire scored from 0 to 28, with higher scores
indicating more symptoms [19, 20]. In addition, participants
completed the International Consultation on Incontinence
Questionnaire Urinary Incontinence Short Form (ICIQ-UI
SF) [21], the ICIQ Bowel Symptom (ICIQ-BS) [22], POP/
Urinary Incontinence Sexual Questionnaire 12 (PISQ-12)
[23], and the Short FormHealth Questionnaire of 12 questions
(SF-12) a generic measure of perceived health [23, 24]. An
outcome physiotherapist was trained at each centre to assess
the degree of prolapse using the POP Quantification (POP-Q)
scale, and all were experienced in undertaking digital PFM
evaluation using the PERFECT [P representing power (or
pressure, a measure of strengthusing a manometric
perineometer), E = endurance,R = repetitions, F = fast con-
tractions, and ECT = everycontraction timed] and Modified
Oxford scales. The former is a feasible and reliable assessment
for physiotherapists to undertake [25], and the latter has high
interexaminer and test–retest reliability [26]. The outcome
therapist was blinded to group allocation, and the same centre
therapist undertook all assessments at all time points (0, 6 and
12 months) with the women in the modified dorsal lithotomy
position
An exit questionnaire was developed and sent to partici-
pants with the final questionnaires. This had six sections with
two to four questions per section. Each question contained
Yes/No and Can’t Remember boxes, with space for any addi-
tional comments. Sections included feedback on prestudy
informat ion, outcome measures and assessment
burdensomeness and intervention acceptability. Results of this
questionnaire will also feed into the proposed RCT.
Data analysis
As this was a pilot study, many outcomes were related to the
feasibility of undertaking the RCT; e.g. willingness of clini-
cians to recruit and of participants to be randomised, number
of eligible patients and follow-up rates, response rates, com-
pliance and standard deviation (SD) for our primary outcome
measures (OCM) to allow sample size calculation for the main
RCT. Comparison of treatment effectiveness was a secondary
outcome, so statistics are largely descriptive; statistical testing
was kept to a minimum. Tables showing means and SDs (and
other summary statistics as appropriate) for both groups were
produced. Unpaired t tests or nonparametric equivalents were
employed to test for differences in continuous outcomes be-
tween groups, and mean differences with 95 % confidence
intervals (CI) are reported where appropriate. Data were
blinded before analysis on an intention-to-treat basis and
stored in accordance with the UK Data Protection Act 1998.
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Results
Sampling and recruitment was undertaken as shown in the
Consolidated Standards of Reporting Trials (CONSORT) flow
chart (Fig. 1). Fifty-seven participants were randomised: 28 to
the TG and 29 to the CG. Median age was 60 (range 35–80)
years, average number of births was 2.19 (SD 0.83), mean body
mass index (BMI) was 27 (SD 3.0), mean duration of prolapse
symptoms was 17months and themost common prolapse stage
was II, with 50 % being anterior prolapse. Both groups dem-
onstrated similar symptom severity at baseline (Table 1), except
that the TGwas more troubled by bowel dysfunction compared
with the CG. When comparing POP-Q assessment at baseline,
those in the TG were more likely to demonstrate posterior
prolapse. Of patients who were approached and were eligible,
approximately 50 % agreed to participate. No adverse events
were reported during the follow-up period.
Retention and adherence
One centre recruited and retained participants above target
(target n=20: n=27). There were delays in recruiting to time
and target at two centres, which meant that no participants at
one site and only four at the other had 12-month follow-up
data; thus, overall results at 12 months are weighted to one
unit. The questionnaire response rates at 6 months were TG=
23/28 (82 %) and CG=25/29 (86 %). Completion of the
questionnaires at 12 months was 14/28 (50 %) in the TG
and 13/29 (44%) in the CG; due to the recruitment difficulties,
20 participants failed to reach the 12-month stage, and one
was lost to follow-up. Of those in the centre that recruited to
target, TG=11/14 (92 %) and CG=12/13 (78 %) returned the
questionnaires at 12 months (Table 2). Attendance at the POP-
Q and PFM review appointment was TG=26/28 (92 %), CG
26/29 (89 %) at baseline; TG=14/28 (50 %) and CG=11/29
(28 %) at 6 months; and TG= 5/28 (18 %) and CG= 5/29
(17 %) at 12 months (Tables 3 and 4). Adherence of therapists
to the intervention protocol appeared high (as per information
accessed from assessment and treatment forms). Adherence to
home exercise was assessed using a home exercise diary.
Although overall the compliance of completion of this diary
was poor, 8/28 (28 %) completed all diaries, and those that
were completed recorded good compliance.
Symptoms
The primary symptom outcome measure was the POP-SS
completed by women in their questionnaires. Both groups
111 Women
Approached
Number ineligible n=42
Reasons for ineligibility:
Unwilling to be contacted n=35
Other n=7
Number eligible n=69
Number randomised n=57
Control Group
n=29
No pre-op appointment
Treatment Group
n=28
One Pre op appointment
Withdrew n=2
(post op/surgery complications)
Received phone call + booklet
n=27
Withdrew n=2
(post op complications)
Received phone call + booklet
n=26
Pre-Randomisation
Withdrew n=12
Surgery
n=57
Intervention
2-7 appointments
No Contact
6 month follow-up
Withdrew 3
2 could not attend, 1 unwell
n=23
6 month follow-up
Withdrew 2
1 lost to contact, 1 unwell
n=25
12 month follow-up
12 ran out of time
n=13
12 month follow-up
8 ran out of time
1 lost to follow-up
n=14
Fig. 1 Consolidated Standards of
Reporting Trials (CONSORT)
flow diagram
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reported similar improvement from baseline to 6 months. Sim-
ilar improvements were also reported in the ICIQ-UI, ICIQ-BS
and SF-12 from baseline to 6 months (Table 1). There was a
significant difference in POP-SS and SF-12 scores between
groups at 12 months [mean difference (MD) 3.94545; 95 %
CI 1.358–6.750; t=3.248, p=0.006); MD −6.88333; 95 % CI
−11.344 to −2.431, t=−3.218, p=0.004] (Table 5).
Outcomes recorded by the outcome physiotherapist
POP-Q (Table 3)
Preoperatively, 51 women were assessed, 33/51 (65 %) with
stage II and 14/51 (27 %) with stage III POP. At 6 months
postoperatively, the numbers attending for assessment were
TG =14/28(50 %) and CG = 11/29(28 %); at 12 months, 5/28
(18 %) and 5/29 (17 %) attended. No woman in either group
demonstrated prolapse greater than stage 1 at either 6 or
12 months.
Pelvic floor muscle assessment (Table 4)
Participants in the TG recorded a mean improvement in PFM
strength of 1.0 in the Oxford classification, whereas those in
the CG recorded an improvement of 0.06. Holding time and
number of repetitions also increased more in the TG than the
CG from baseline to 6 months. At 6 months, 13/14 (92 %) of
the TG could contract and hold the contraction whilst
coughing, compared with 10/15 (66 %) in the CG (Table 4).
Exit questionnaire
The exit questionnaire was completed and returned by 22 par-
ticipants (11 from each group). Those in the TG reported that
they found being in the studywas useful, agreed that the number
of visits was about right, and would take part again, with eight
reporting continuation of their PFM exercises. Of those in the
CG, five expressed disappointment about being in the CG; 7/11
had sought additional information from web sites/books or local
Pilates-type classes led by a eoman’s health physiotherapist, and
8/11 said theywere dissatisfiedwith the information on postope-
rative recovery/PFMT they received, i.e. usual care.
Feedback from outcome (OP) and treatment (TP)
physiotherapists
TPs reported that most participants were very pleased with the
additional support and felt it helped with their recovery. Keep-
ing track of the surgery dates was difficult at two centres, as the
physiotherapists did not have direct access to the surgery lists.
Sample size calculation
Study results provided us with the information to undertake a
sample size calculation for a future pragmatic multicentre
RCT of effectiveness using the women’s symptoms, as mea-
sured by the POP-SS as primary outcome. The minimally
important clinical difference (MICD) in the POP-SS is 1.5
[20]. Thus, we would want a future trial to have sufficient
statistical power to detect a difference between groups of 1.5
in the POP-SS, as women have indicated that this equates to a
Table 1 Summary of prolapse-related quality of life (QoL) scores at baseline and 6 months for treatment (TG) and control (CG) groups (all centres)
Measurement TG baseline,
mean (SD)
CG baseline,
mean (SD)
TG, mean (SD) CG, mean (SD) Between-group difference in change,
(95 % CI), t value, p value
POP-SS
Lower scores indicate better QoL
13.40 (6.57) 13.44 (5.69) 3.90 (4.54)
t=6.70
p=0.00
3.72 (3.89)
t=7.51
p=0.00
(−2.561 to 2.192)
−0.156
0.876
ICIQ-UI; lower scores indicate better QoL 6.21 (4.68) 6.13 (6.62) 2.75 (3.67)
t=3.618
p=0.01
3.32 (3.47)
t=2.062
p=0.05
(−1.48 to 2.97)
−0.050
0.96
ICIQ-BS; lower scores indicate better QoL 16.92 (6.08) 13.55 (3.07) 11.59 (3.83)
t=4.42
p=0.00
12.42 (3.38)
t=1.16
p=0.25
(−1.26 to 2.93)
−2.64
0.11
SF-12; higher score indicates better QoL 33.57 (3.55) 35.14 (6.73) 46.43 (13.35)
t=4.02
p=0.01
49.12 (19.12)
t=3/268
p=0.03
(−6.97 to 12.35)
0.559
0.579
POP-SSPelvic Organ Prolapse Symptom Score, ICIQ-BS International Consultation on Incontinence Questionnaire Bowel Symptom, SF-12Short Form
Health Survey of 12 items, SD standard deviation, CI confidence interval
Table 2 Adherence to completion of outcome measure questionnaires
All questionnaires Treatment
group
Control
group
Newcastle (n=27);
CG/TG
Baseline 28 (100 %) 29 (100 %) 13/13; 14/14
6 months 23 (82 %) 25 (86 %) 12/13; 12/14
12 months 14 (50 %) 13 (44 %) 12/13; 11/14
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meaningful change in symptoms. Using the SD of the POP-SS
at 12months from our pilot trial (SD=4) as an estimate of likely
variability in the outcomemeasure, this would suggest a sample
size of 150 per group to achieve 90 % power at the 5 % level of
significance. Allowing for 30 % attrition, this would bring the
sample size to 214 per group. This calculation, however, is
primarily based on evidence from the one centre that had data at
12 months (as explained earlier, the other two centres did not
recruit in time to allow completion of the 12-month data), so
this calculation may overestimate participation. However, as
discussed later, many lessons have been learned from under-
taking this pilot study that would enhance recruitment; but
based on our findings, we estimate we would need 20 sites
recruiting 20 patients each over a period of 2 years.
Discussion
To our knowledge, this is the first pilot RCT comparing ad-
junctive perioperative PFMT and lifestyle advice to standard
care following surgery for POP, using prolapse symptoms as
the primary outcome measure. We achieved our objective of
demonstrating that such a clinical trial was feasible and believe
the recruitment of our proposed number of centres with ade-
quate TP and OP staff is possible: e.g. in a trial of outpatient
PFMTas treatment for POP, we recruited 23 centres in the UK
at which we had two physiotherapists involved; many of these
centres also undertake gynaecological surgery [25]. The main
difficulty with this study was slow recruitment at two centres,
and most 12-month data came from one centre. This centre,
in which processes were robust and staff were established,
recruited to time and target. However, at one other centre, the
principal investigator (PI) changed National Health System
(NHS) location, which delayed commencement for a consid-
erable time; at the other centre, the TP was on long-term sick
leave with no replacement. Whereas similar events may
occur in the RCT, we learned from this experiences and
would more quickly withdraw centres who were not
recruiting to target and have additional sites prepared to
participate. The study setup time and recruitment period
would also need to be extended, which would give some
flexibility for research approvals and training to be complet-
ed. In addition, at each centre, we would have a dedicated
research nurse/allied health profession who would approach
potential participants previously identified by screening pa-
tient notes. This would reduce the burden on local PIs during
busy clinics. Approximately 50 % of eligible patients were
willing to be randomised between treatment and control
arms, and those in the TG attended 80 % of treatment
sessions and appeared adherent to the prescribed exercises
and advice. Overall, completion of outcome measures at 6
months was 84 %. Completion at 12 months was 85 % of the
centre that recruited to time. This level of completion of
postal questionnaires is similar to other studies we have
completed; however, we will put in place strategies to ensure
we maintain contact with participants in the long term; e.g.
we have experience in keeping in contact with patients long
term by using such details as a relatives’ or friends’ contact
(supplied with permission). Attendance at follow-up ap-
pointments for PFM assessment and POP-Q were disap-
pointing and not equivalent to some other studies; e.g. the
Pelvic Organ Prolapse Physiotherapy (POPPY) study had a
Table 3 Pelvic organ prolapse
(POP) stage as measured using
the POP Quantification (POP-Q)
at baseline and 6 and 12 months
TG treatment group, CG control
group
Stage of Prolapse Baseline Baseline 6 month 6 month 12 month 12 month
TG (n=26) CG (n=26) TG (n=14) CG (n=13) TG (n=5) CG (n=5)
Stage 0 0 0 10 11 5 4
Stage I 2 (7 %) 2 (7 %) 4 2 1
Stage II 18 (64 %) 15 (57 %)
Stage III 5 (20 %) 9 (34 %)
Table 4 Pelvic floor muscle assessment
Measure TG baseline CG baseline TG 6 months CG 6 months TG 12 months CG 12 months
n=25 n=26 n=14 n=15 n=5 n=5
mean (SD) mean (SD) mean (SD) mean (SD) mean (SD) mean (SD)
Power 2.56 (0.935) 2.81 (1.021) 3.57 (0.646) 2.87 (1.060) 3.50 (0.654) 2.36 (0.809)
Endurance (s) 7.13 (3.123) 6.6 (3.279) 8.43 (2.441) 7.30 (2.720) 7.00 (2.453) 7.27 (2.240)
Repetitions 6.41 (2.501) 5.88 (3.0470) 7.93 (2.018) 6.62 (2.329) 10 (2.345) 7.91 (2.256)
Hold with cough: Yes/N 12/25 (48 %) 13/26 (50 %) 13/14 (92 %) 10/15 (66 %) 5/5 (100 %) 3/5 (60 %)
TG treatment group, CG control group, SD standard deviation
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77 % (365/477) attendance for the 6-month review [14],
and the Pelvic Floor Muscle Training to Prevent Pelvic
Organ Prolapse in Women (PREVPROL) study 70 % at
1 year (280/400) (personal communication). In the defini-
tive trial, we intend to apply for funding to cover travel
and parking expenses of participants attending for follow-
up assessments and be more proactive in organising ap-
pointments at a more suitable time for woman who may
have returned to work, with the possible use of incentives
on completion. Long-term follow-up would be imperative
in the proposed RCT, and we would apply for funding to
allow us to access NHS data on these patients for at least
10 years, as preventing POP recurrence necessitating fur-
ther NHS consultation and/or surgery is a primary aim. In
addition, we could obtain consent to send a questionnaire
to women at 5 and 10 years to capture health, lifestyle,
and activity.
Our QoL and symptom questionnaires appear to be sensi-
tive within this population and were not overburdensome to
participants. There is the option of using perineometry or
transperineal ultrasound (US) rather than or as well as digital
vaginal assessment of PFMs. The PERFECT and Modified
Oxford scale we used is widely taught in the UK and has been
shown to be reliable, as well as providing an opportunity to
correct technique [26]. The Peritron perineometer is a simple
and reliable objective measure of PFM strength via vaginal
squeezing pressure measurement [27], although Ferreira et al.
recommended that for research purposes, the same examiner
assess and reassess patients for both the Peritron and the
Oxford grading scale [28]. Transperineal US demonstrates
reliability and may also provide evidence of effect [29].
Monitoring adherence to PFM exercise is important both in
the short- and long term. Home exercise diaries are notorious
for lack of completion and/or lack of fidelity. We are
reviewing the use of diaries within both research and clinical
practice and looking at electronic means of recording exercise
adherence with the potential to identify the optimal method for
future trials.
To undertake such a study would be relatively expensive in
terms of NHS excess treatment costs. To cover the additional
visits, it would cost approximately £280 per patient in the
treatment arm. Research support costs for outcome measures
such as pelvic floor assessment and POP-Q would also be
required. It is therefore important that within the main trial an
economic evaluation is undertaken to establish whether this
intervention is likely to be cost effective.
It would appear that patients in the treatment group report-
ed fewer symptoms at 12 months than those in the control
group (Table 5). However, we suggest that this finding be
treated with caution, as it is based primarily on responses from
one site. We recognise that opinions vary as to validity of
reporting statistical analysis in an external pilot study; how-
ever, we wanted to look at the size difference between groups
to see whether data would give us at least an indication of
whether the intervention is potentially effective. It may be a
real effect observed at one good site, which would not be
replicated more generally if there was a wider rollout and
therefore does not preclude the need for a larger pragmatic
trial to establish effectiveness. Moreover, in order to establish
benefit, a 5- to 10-year follow-up would be required, as
second repair procedures occur principally within this time
frame [30].
Table 5 Summary of questionnaires at baseline and 6 and 12 months (Newcastle only)
Measurement Treatment
group baseline
Control
group baseline
Treatment group Control group Treatment group Control group Between-group difference:
6 months 6 months 12 months 12 months 0–12 months
mean/SD mean/SD mean/SD mean/SD mean/SD mean/SD (95% CI), t, p value
POP-SS 13.38 (5.76) 14.69 (5.40) 3.27 (4.50) 5.41 (5.96) 2.45 (2.42) 6.40 (3.40) (1.35 to 6.75)
t=3.24
p=0.06
ICIQ-UI 6.30 (7.69) 6.30 (4.47) 3.54 (4.69) 3.84 (3.69) 1.30 (1.60) 3.23 (3.60) (−0.33 to 4.18)
t=1.75
p=0.92
ICIQ-BS 14.53 (5.36) 13.92 (3.64) 12.90 (5.02) 12.85 (3.95) 11.40 (4.52) 11.38 (3.01) (−4.22 to −3.00)
t=−0.348
p=0.731
SF-12 35.20 (0.92) 34.83 (6.01) 42.82 (3.68) 40.20 (5.20) 42.58 (3.60) 35.70 (6.29) (−11.34 to −2.43)
t=−3.218
p=0.04
PISQ 42.69 (23.90) 38.53 (19.91) 36.23 (26.56) 36.84 (22.69) 31.07 (23.19) 29.38 (17.76) (−13.65 to 21.96)
t=0.481
p=0.635
POP-SSPelvic Organ Prolapse Symptom Score, ICIQ-BS International Consultation on Incontinence Questionnaire Bowel Symptom, SF-12Short Form
Health Survey of 12 items, PISQ POP/Urinary Incontinence Sexual Questionnaire, SD standard deviation, CI confidence interval
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This pilot study and the literature also raise several
questions. For example, how much benefit from, and to
what extent do patients adhere to, lifestyle advice, and
what advice should patients receive following POP sur-
gery? Our study supports findings from clinician sur-
veys that unclear and conflicting advice about the
timing of return to activities of daily living and sport
is often provided to patients [9–13]. In addition a re-
view by Murphy et al. [31] reported limited data to
guide many other aspects of postoperative care. A liter-
ature review undertaken in 2013 reported that no
randomised or prospective cohort studies that reported
the association between postoperative activity and sur-
gical success after pelvic floor repair could be identified
[32], although Barber et al. published a protocol on two
types of vaginal-vault surgery and PFMT [33]. Before
commencing a definitive trial, efforts should be made to
define the most appropriate advice for women following
POP surgery. Consensus methods, such as the Delphi
survey technique, could be used to transform opinion
into group consensus [34].
Conclusion
The aim of this study was to determine the feasibility of a
future definitive trial; hence, we should not draw any definite
conclusions about treatment effect. We believe that with mod-
ifications to design, such an RCT is practical and would
provide evidence from which clinical guidance could be de-
veloped regarding the place of perioperative PFMT to limit
POP recurrence.
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